1
|
Saletta F, Wadham C, Ziegler DS, Marshall
GM, Haber M, McCowage G, Norris MD and Byrne JA: Molecular
profiling of childhood cancer: Biomarkers and novel therapies. BBA
Clin. 1:59–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Shallis RM, Wang R, Davidoff A, Ma X and
Zeidan AM: Epidemiology of acute myeloid leukemia: Recent progress
and enduring challenges. Blood Rev. 36:70–87. 2019. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kadia TM, Ravandi F, Cortes J and
Kantarjian H: New drugs in acute myeloid leukemia. Ann Oncol.
27:770–778. 2016. View Article : Google Scholar : PubMed/NCBI
|
4
|
Burnett A, Wetzler M and Löwenberg B:
Therapeutic advances in acute myeloid leukemia. J Clin Oncol.
29:487–494. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gugnoni M and Ciarrocchi A: Long noncoding
RNA and epithelial mesenchymal transition in cancer. Int J Mol Sci.
20:19242019. View Article : Google Scholar
|
7
|
Cruz-Miranda GM, Hidalgo-Miranda A,
Bárcenas-López DA, Núñez-Enríquez JC, Ramírez-Bello J,
Mejía-Aranguré JM and Jiménez-Morales S: Long non-coding RNA and
acute leukemia. Int J Mol Sci. 20:7352019. View Article : Google Scholar
|
8
|
Wang G, Li X, Song L, Pan H, Jiang J and
Sun L: Long noncoding RNA MIAT promotes the progression of acute
myeloid leukemia by negatively regulating miR-495. Leuk Res.
87:1062652019. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhang X and Tao W: Long noncoding RNA
LINC00152 facilitates the leukemogenesis of acute myeloid leukemia
by promoting CDK9 through miR-193a. DNA Cell Biol. 38:236–242.
2019. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang D, Zeng T, Lin Z, Wang F, Tang L,
Wang L, Tang D, Chen P and Yang M: Long non-coding RNA SNHG5
regulates chemotherapy resistance through the miR-32/DNAJB9 axis in
acute myeloid leukemia. Biomed Pharmacother. 123:1098022020.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Wu K, Li J, Qi Y, Zhang C, Zhu D, Liu D
and Zhao S: SNHG14 confers gefitinib resistance in non-small cell
lung cancer by up-regulating ABCB1 via sponging miR-206-3p. Biomed
Pharmacother. 116:1089952019. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhang YY, Li M, Xu YD and Shang J: LncRNA
SNHG14 promotes the development of cervical cancer and predicts
poor prognosis. Eur Rev Med Pharmacol Sci. 23:3664–3671.
2019.PubMed/NCBI
|
13
|
Liu Z, Yan Y, Cao S and Chen Y: Long
non-coding RNA SNHG14 contributes to gastric cancer development
through targeting miR-145/SOX9 axis. J Cell Biochem. 119:6905–6913.
2018. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wang Q, Teng Y, Wang R, Deng D, You Y,
Peng Y, Shao N and Zhi F: The long non-coding RNA SNHG14 inhibits
cell proliferation and invasion and promotes apoptosis by sponging
miR-92a-3p in glioma. Oncotarget. 9:12112–12124. 2018. View Article : Google Scholar : PubMed/NCBI
|
15
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wallace JA and O'Connell RM: MicroRNAs and
acute myeloid leukemia: Therapeutic implications and emerging
concepts. Blood. 130:1290–1301. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhang J, Qin J and Su Y: miR-193b-3p
possesses anti-tumor activity in ovarian carcinoma cells by
targeting p21-activated kinase 3. Biomed Pharmacother.
96:1275–1282. 2017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Song B, Du J, Song DF, Ren JC and Feng Y:
Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and
miR-1179 may contribute to the progression of gastric cancer. Biol
Res. 51:442018. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yang Z, Zhuang Q, Hu G and Geng S: MORC4
is a novel breast cancer oncogene regulated by miR-193b-3p. J Cell
Biochem. 120:4634–4643. 2019. View Article : Google Scholar : PubMed/NCBI
|
20
|
Bhayadia R, Krowiorz K, Haetscher N,
Jammal R, Emmrich S, Obulkasim A, Fiedler J, Schwarzer A, Rouhi A,
Heuser M, et al: Endogenous tumor suppressor microRNA-193b:
Therapeutic and prognostic value in acute myeloid leukemia. J Clin
Oncol. 36:1007–1016. 2018. View Article : Google Scholar : PubMed/NCBI
|
21
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang H, Chen W, Yang P, Zhou J, Wang K and
Tao Q: Knockdown of linc00152 inhibits the progression of gastric
cancer by regulating microRNA-193b-3p/ETS1 axis. Cancer Biol Ther.
20:461–473. 2019. View Article : Google Scholar : PubMed/NCBI
|
23
|
Xie SD, Qin C, Jin LD, Wang QC, Shen J,
Zhou JC, Chen YX, Huang AH, Zhao WH and Wang LB: Long noncoding RNA
SNHG14 promotes breast cancer cell proliferation and invasion via
sponging miR-193a-3p. Eur Rev Med Pharmacol Sci. 23:2461–2468.
2019.PubMed/NCBI
|
24
|
Swerdlow SH, Campo E, Harris NL, Jaffe ES,
Pileri SA, Stein H and Thiele J: WHO Classification of Tumours of
HaematoPoietic and Lymphoid Tissues, 4th edition. WHO Press;
Geneva: 2008
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Liang Y, Li E, Zhang H, Zhang L, Tang Y
and Wanyan Y: Silencing of lncRNA UCA1 curbs proliferation and
accelerates apoptosis by repressing SIRT1 signals by targeting
miR-204 in pediatric AML. J Biochem Mol Toxicol. 34:e224352020.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Liu Y, Gao X and Tian X: High expression
of long intergenic non-coding RNA LINC00662 contributes to
malignant growth of acute myeloid leukemia cells by upregulating
ROCK1 via sponging microRNA-340-5p. Eur J Pharmacol.
859:1725352019. View Article : Google Scholar : PubMed/NCBI
|
28
|
Di W, Weinan X, Xin L, Zhiwei Y, Xinyue G,
Jinxue T and Mingqi L: Long noncoding RNA SNHG14 facilitates
colorectal cancer metastasis through targeting EZH2-regulated
EPHA7. Cell Death Dis. 10:5142019. View Article : Google Scholar : PubMed/NCBI
|
29
|
Ji N, Wang Y, Bao G, Yan J and Ji S:
LncRNA SNHG14 promotes the progression of cervical cancer by
regulating miR-206/YWHAZ. Pathol Res Pract. 215:668–675. 2019.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Pu J, Wei H, Tan C, Qin B, Zhang Y, Wang A
and Wang J: Long noncoding RNA SNHG14 facilitates hepatocellular
carcinoma progression through regulating miR-4673/SOCS1. Am J
Transl Res. 11:5897–5904. 2019.PubMed/NCBI
|
31
|
Choi KH, Shin CH, Lee WJ, Ji H and Kim HH:
Dual-strand tumor suppressor miR-193b-3p and −5p inhibit malignant
phenotypes of lung cancer by suppressing their common targets.
Biosci Rep. 39:BSR201906342019. View Article : Google Scholar : PubMed/NCBI
|
32
|
Mets E, Van der Meulen J, Van Peer G,
Boice M, Mestdagh P, Van de Walle I, Lammens T, Goossens S, De
Moerloose B, Benoit Y, et al: MicroRNA-193b-3p acts as a tumor
suppressor by targeting the MYB oncogene in T-cell acute
lymphoblastic leukemia. Leukemia. 29:798–806. 2015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Chen J, Zhang X, Lentz C, Abi-Daoud M,
Paré GC, Yang X, Feilotter HE and Tron VA: miR-193b regulates Mcl-1
in melanoma. Am J Pathol. 179:2162–2168. 2011. View Article : Google Scholar : PubMed/NCBI
|
34
|
Yin W, Nie Y, Chen L, Wang Q, Liu S, He X
and Wang W: Deregulation of microRNA-193b affects the proliferation
of liver cancer via myeloid cell leukemia-1. Oncol Lett.
15:2781–2788. 2018.PubMed/NCBI
|
35
|
Li C, Song Y and Li P: MCL1 regulates cell
death, tumor growth and chemosensitivity to sabutoclax in ovarian
adenocarcinoma. Cell Tissue Res. 379:625–633. 2020. View Article : Google Scholar : PubMed/NCBI
|
36
|
Zhou C, Li G, Zhou J, Han N, Liu Z and Yin
J: miR-107 activates ATR/Chk1 pathway and suppress cervical cancer
invasion by targeting MCL1. PLoS One. 9:e1118602014. View Article : Google Scholar : PubMed/NCBI
|
37
|
Wu S, Liu F, Xie L, Peng Y, Lv X, Zhu Y,
Zhang Z and He X: miR-125b Suppresses proliferation and invasion by
targeting MCL1 in gastric cancer. Biomed Res Int. 2015:3652732015.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Huang Y, Luo H, Li F, Yang Y, Ou G, Ye X
and Li N: LINC00152 down-regulated miR-193a-3p to enhance MCL1
expression and promote gastric cancer cells proliferation. Biosci
Rep. 38:BSR201716072018. View Article : Google Scholar : PubMed/NCBI
|